Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Strains and Early Life Hospital Admissions in Guinea-Bissau
NCT02447536Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bacillus calmette-guerin substrain danish 1331 live antigen, BCG-Russia-I in Tuberculosis (TB), pneumonia, sepsis, sponsored by Bandim Health Project. Started Dec 2014; status: completed.
02
Drugs
bacillus calmette-guerin substrain danish 1331 live antigenBCG-Russia-I
03
Conditions
Tuberculosis (TB)pneumoniasepsis
Beyond the preview
Go deeper on NCT02447536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447536.